Jade (Cullinan Therapeutics/Fred Hutchinson Cancer Research)

N/A

Report date: 2024/04/25 14:31:59

Base Information

Drug NameJade (Cullinan Therapeutics/Fred Hutchinson Cancer Research)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCullinan Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCullinan Therapeutics IncFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A